Phibro Animal Health | PAHC - 资产

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.48B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	资产	更改		日
Align Technology	USD 6.42B		103.41M	2026-06
ANI Pharmaceuticals	USD 1.49B		72.14M	2026-06
Aurora Cannabis	CAD 601.09M		174.2M	2026-03
Bristol-Myers Squibb	USD 87.63B		1.16B	2026-06
Canopy Growth	CAD 1.12B		12.54M	2026-03
Corcept Therapeutics	USD 888.7M		73.82M	2026-06
Eli Lilly	USD 142.28B		25.71B	2026-06
Henry Schein	USD 11.38B		77M	2026-06
Idexx Laboratories	USD 3.44B		56.84M	2026-06
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Merck	USD 129.8B		1.12B	2026-06
Nektar Therapeutics	USD 763.27M		482.86M	2026-03
Pacira	USD 1.24B		35.44M	2026-06
Phibro Animal Health	USD 1.5B		56.12M	2026-06
Prestige Brands	USD 4.57B		1.07B	2026-06
Supernus Pharmaceuticals	USD 1.43B		72.62M	2026-06
Zoetis	USD 15.08B		77M	2026-06